Carbon monoxide liberated from carbon monoxide-releasing molecule exerts an anti-inflammatory effect on dextran sulfate sodium-induced colitis in mice

Digestive Diseases and Sciences

Volumn 56, Issue 6, 2011, Pages 1663-1671

  Takagi, Tomohisa ^a   Naito, Yuji ^a   Uchiyama, Kazuhiko ^a   Suzuki, Takahiro ^a   Hirata, Ikuhiro ^a   Mizushima, Katsura ^a   Tsuboi, Hisato ^a   Hayashi, Natsuko ^a   Handa, Osamu ^a   Ishikawa, Takeshi ^a   Yagi, Nobuaki ^a   Kokura, Satoshi ^a   Ichikawa, Hiroshi ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Carbon monoxide (CO); CO releasing molecule; Dextran sulfate sodium (DSS) induced colitis; Keratinocyte chemoattractant (KC); Neutrophil; Nuclear factor kappa B (NF B); TNF

Indexed keywords

ANTIINFLAMMATORY AGENT; CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE 2; CHEMOATTRACTANT; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KERATINOCYTE CHEMOATTRACTANT; MESSENGER RNA; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; IN VITRO STUDY; INTESTINE MUCOSA; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARBON MONOXIDE; CHEMOTACTIC FACTORS; COLITIS; COLON; DEXTRAN SULFATE; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; ORGANOMETALLIC COMPOUNDS; PEROXIDASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959699593     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-010-1484-y     Document Type: Article

References (59)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-429. (Pubitemid 34851835)
2. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427-434. (Pubitemid 47123518)
3. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997;37:517-554. (Pubitemid 27238886)
4. Naito Y, Takagi T, Yoshikawa T. Heme oxygenase-1: A new therapeutic target for inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(Suppl 1):177-184. (Pubitemid 39120291)
5. Sassa S. Biological implications of heme metabolism. J Clin Biochem Nut. 2006;38:138-155. (Pubitemid 43761949)
6. Alcaraz MJ, Fernandez P, Guillen MI. Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr Pharm Des. 2003;9:2541-2551. (Pubitemid 37236372)
7. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med. 2002;8:240-246.
8. Morse D, Choi AM. Heme oxygenase-1: from bench to bedside. Am J Respir Crit Care Med. 2005;172:660-670. (Pubitemid 41324219)
9. Nakao A, Kaczorowski DJ, Sugimoto R, Billiar TR, McCurry KR. Application of heme oxygenase-1, carbon monoxide and biliverdin for the prevention of intestinal ischemia/reperfusion injury. J Clin Biochem Nutr. 2008;42:78-88. (Pubitemid 351916606)
10. Otterbein LE, Mantell LL, Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol. 1999;276:L688-L694. (Pubitemid 29211371)
11. Kaizu T, Ikeda A, Nakao A, et al. Protection of transplant-induced hepatic ischemia/reperfusion injury with carbon monoxide via mek/erk1/2 pathway downregulation. Am J Physiol Gastrointest Liver Physiol. 2008;294:G236-G244.
12. Nakao A, Kimizuka K, Stolz DB, et al. Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am J Pathol. 2003;163:1587-1598. (Pubitemid 37175105)
13. Nakao A, Toyokawa H, Abe M, et al. Heart allograft protection with low-dose carbon monoxide inhalation: effects on inflammatory mediators and alloreactive t-cell responses. Transplantation. 2006;81:220-230.
14. Neto JS, Nakao A, Kimizuka K, et al. Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol Renal Physiol. 2004;287:F979-F989. (Pubitemid 39391095)
15. Takagi T, Naito Y, Inoue M, et al. Inhalation of carbon monoxide ameliorates collagen-induced arthritis in mice and regulates the articular expression of il-1beta and mcp-1. Inflammation. 2009;32:83-88.
16. Tsui TY, Obed A, Siu YT, et al. Carbon monoxide inhalation rescues mice from fulminant hepatitis through improving hepatic energy metabolism. Shock. 2007;27:165-171. (Pubitemid 46105833)
17. Hegazi RA, Rao KN, Mayle A, Sepulveda AR, Otterbein LE, Plevy SE. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J Exp Med. 2005;202:1703-1713. (Pubitemid 41815876)
18. Zuckerbraun BS, Otterbein LE, Boyle P, et al. Carbon monoxide protects against the development of experimental necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2005;289:G607-G613. (Pubitemid 41216400)
19. Takagi T, Naito Y, Mizushima K, et al. Inhalation of carbon monoxide ameliorates tnbs-induced colitis in mice through the inhibition of tnf-alpha expression. Dig Dis Sci. 2010;55:2797-2804.
20. Guo Y, Stein AB, Wu WJ, et al. Administration of a co-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol. 2004;286:H1649-H1653. (Pubitemid 38525450)
21. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res. 2002;90:E17-E24.
22. Taille C, El-Benna J, Lanone S, Boczkowski J, Motterlini R. Mitochondrial respiratory chain and nad(p)h oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J Biol Chem. 2005;280:25350-25360. (Pubitemid 40962237)
23. Clark JE, Naughton P, Shurey S, et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res. 2003;93:e2-e8.
24. Uchiyama K, Naito Y, Takagi T, et al. Carbon monoxide enhance colonic epithelial restitution via fgf15 derived from colonic myofibroblasts. Biochem Biophys Res Commun. 2010;391:1122-1126.
25. Cepinskas G, Katada K, Bihari A, Potter RF. Carbon monoxide liberated from carbon monoxide-releasing molecule corm-2 attenuates inflammation in the liver of septic mice. Am J Physiol Gastrointest Liver Physiol. 2008;294:G184-G191.
26. Vera T, Henegar JR, Drummond HA, Rimoldi JM, Stec DE. Protective effect of carbon monoxide-releasing compounds in ischemia-induced acute renal failure. J Am Soc Nephrol. 2005;16:950-958. (Pubitemid 41710305)
27. Sun BW, Chen ZY, Chen X, Liu C. Attenuation of leukocytes sequestration by carbon monoxide-releasing molecules: liberated carbon monoxide in the liver of thermally injured mice. J Burn Care Res. 2007;28:173-181. (Pubitemid 46087876)
28. Sun B, Sun H, Liu C, Shen J, Chen Z, Chen X. Role of co-releasing molecules liberated CO in attenuating leukocytes sequestration and inflammatory responses in the lung of thermally injured mice. J Surg Res. 2007;139:128-135. (Pubitemid 46482566)
29. Katada K, Bihari A, Mizuguchi S, et al. Carbon monoxide liberated from co-releasing molecule (corm-2) attenuates ischemia/reperfusion (i/r)-induced inflammation in the small intestine. Inflammation. 2010;33:92-100.
30. Chen P, Sun B, Chen H, et al. Effects of carbon monoxide releasing molecule-liberated CO on severe acute pancreatitis in rats. Cytokine. 2010;49:15-23.
31. Naito Y, Katada K, Takagi T, et al. Rosuvastatin, a new hmg-coa reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice. Int J Mol Med. 2006;17:997-1004.
32. Takagi T, Naito Y, Tomatsuri N, et al. Pioglitazone, a ppar-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the nf-kappab-cytokine cascade. Redox Rep. 2002;7:283-289. (Pubitemid 36032915)
33. Tsoyi K, Lee TY, Lee YS, Kim HJ, Seo HG, Lee JH. Chang KC: Heme-oxygenase-1 induction and carbon monoxide-releasing molecule inhibit lipopolysaccharide (lps)-induced high-mobility group box 1 release in vitro and improve survival of mice in lps- and cecal ligation and puncture-induced sepsis model in vivo. Mol Pharmacol. 2009;76:173-182.
34. Tsoyi K, Nizamutdinova IT, Jin Jang H, Mun L, Kim HJ, Seo HG, Lee JH, Chang KC: Carbon monoxide from corm-2 reduces hmgb1 release through regulation of ifn-beta/jak-2/stat-1/inos/no signaling but not cox-2 in tlr-activated macrophages. Shock. 2010.
35. Zimmermann A, Leffler CW, Tcheranova D, Fedinec AL, Parfenova H. Cerebroprotective effects of the co-releasing molecule corm-a1 against seizure-induced neonatal vascular injury. Am J Physiol Heart Circ Physiol. 2007;293:H2501-H2507. (Pubitemid 47605896)
36. Chen B, Guo L, Fan C, et al. Carbon monoxide rescues heme oxygenase-1-deficient mice from arterial thrombosis in allogeneic aortic transplantation. Am J Pathol. 2009;175:422-429.
37. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69:238-249.
38. Hausmann M, Obermeier F, Paper DH, et al. In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitis. Clin Exp Immunol. 2007;148:373-381.
39. Obermeier F, Kojouharoff G, Hans W, Scholmerich J, Gross V, Falk W. Interferon-gamma (ifn-gamma)- and tumour necrosis factor (tnf)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (dss)-induced colitis in mice. Clin Exp Immunol. 1999;116:238-245. (Pubitemid 29219719)
40. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol. 1986;251:G567-G574.
41. Whitehead RH, VanEeden PE, Noble MD, Ataliotis P, Jat PS. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult h-2 kb-tsa58 transgenic mice. Proc Natl Acad Sci USA. 1993;90:587-591. (Pubitemid 23028908)
42. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by rna polymerase ii in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;11:1475-1489.
43. Fukuda Y, Matsui T, Suzuki Y, et al. Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study. J Gastroenterol. 2004;39:1158-1164. (Pubitemid 40074281)
44. Naito Y, Takagi T, Yoshikawa T. Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease. J Gastroenterol. 2007;42:787-798. (Pubitemid 47617456)
45. Naito Y, Takagi T, Yoshikawa T. Neutrophil-dependent oxidative stress in ulcerative colitis. J Clin Biochem Nutr. 2007;41:18-26. (Pubitemid 47266169)
46. Breider MA, Eppinger M, Gough A. Intercellular adhesion molecule-1 expression in dextran sodium sulfate-induced colitis in rats. Vet Pathol. 1997;34:598-604. (Pubitemid 127470932)
47. Natsui M, Kawasaki K, Takizawa H, et al. Selective depletion of neutrophils by a monoclonal antibody, rp-3, suppresses dextran sulphate sodium-induced colitis in rats. J Gastroenterol Hepatol. 1997;12:801-808. (Pubitemid 28088064)
48. Taniguchi T, Tsukada H, Nakamura H, et al. Effects of the antiicam-1 monoclonal antibody on dextran sodium sulphate-induced colitis in rats. J Gastroenterol Hepatol. 1998;13:945-949. (Pubitemid 28448968)
49. Urquhart P, Rosignoli G, Cooper D, Motterlini R, Perretti M. Carbon monoxide-releasing molecules modulate leukocyte-endothelial interactions under flow. J Pharmacol Exp Ther. 2007;321:656-662. (Pubitemid 46624509)
50. Sun B, Sun Z, Jin Q, Chen X. Co-releasing molecules (corm-2)-liberated CO attenuates leukocytes infiltration in the renal tissue of thermally injured mice. Int J Biol Sci. 2008;4:176-183. (Pubitemid 351876995)
51. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol. 2004;22:891-928. (Pubitemid 38680444)
52. Alzoghaibi MA, Al-Mofleh IA, Al-Jebreen AM. Neutrophil chemokines gcp-2 and gro-alpha in patients with inflammatory bowel disease. J Dig Dis. 2008;9:144-148.
53. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121-127. (Pubitemid 30398626)
54. Kolachala VL, Vijay-Kumar M, Dalmasso G, et al. A2b adenosine receptor gene deletion attenuates murine colitis. Gastroenterology. 2008;135:861-870.
55. Shea-Donohue T, Thomas K, Cody MJ, et al. Mice deficient in the cxcr2 ligand, cxcl1 (kc/gro-alpha), exhibit increased susceptibility to dextran sodium sulfate (dss)-induced colitis. Innate Immun. 2008;14:117-124.
56. Hayden MS, West AP, Ghosh S. Nf-kappab and the immune response. Oncogene. 2006;25:6758-6780.
57. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol. 2002;72:847-855. (Pubitemid 35365158)
58. Son DS, Parl AK, Rice VM, Khabele D. Keratinocyte chemoattractant (kc)/human growth-regulated oncogene (gro) chemokines and pro-inflammatory chemokine networks in mouse and human ovarian epithelial cancer cells. Cancer Biol Ther. 2007;6:1302-1312. (Pubitemid 351590387)
59. Sun BW, Jin Q, Sun Y, et al. Carbon liberated from co-releasing molecules attenuates leukocyte infiltration in the small intestine of thermally injured mice. World J Gastroenterol. 2007;13:6183-6190.